BLAU3 Stock Chart & Stats
$8.81
-$0.17(-1.89%)
―
--
Day’s Range― - ―
52-Week Range$8.61 - $11.84
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
R$2.05B
Enterprise Value$2.35K
Total Cash (Recent Filing)R$542.18M
Total Debt (Recent Filing)R$560.29M
Price to Earnings (P/E)7.1
Beta1.08
Next Earnings
Aug 11, 2026EPS Estimate
0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.24
Shares Outstanding233,212,130
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)1.43
Price to Sales (P/S)1.91
P/FCF Ratio-81.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.23
Revenue Forecast (FY)R$1.95B
Blau Farmaceutica SA News
BLAU3 FAQ
What was Blau Farmaceutica SA’s price range in the past 12 months?
Blau Farmaceutica SA lowest stock price was $8.61 and its highest was $11.84 in the past 12 months.
What is Blau Farmaceutica SA’s market cap?
Blau Farmaceutica SA’s market cap is R$2.05B.
When is Blau Farmaceutica SA’s upcoming earnings report date?
Blau Farmaceutica SA’s upcoming earnings report date is Aug 11, 2026 which is in 17 days.
How were Blau Farmaceutica SA’s earnings last quarter?
Blau Farmaceutica SA released its earnings results on May 07, 2026. The company reported $0.166 earnings per share for the quarter, missing the consensus estimate of $0.234 by -$0.068.
Is Blau Farmaceutica SA overvalued?
According to Wall Street analysts Blau Farmaceutica SA’s price is currently Undervalued.
Does Blau Farmaceutica SA pay dividends?
Blau Farmaceutica SA does not currently pay dividends.
What is Blau Farmaceutica SA’s EPS estimate?
Blau Farmaceutica SA’s EPS estimate is 0.33.
How many shares outstanding does Blau Farmaceutica SA have?
Blau Farmaceutica SA has 233,212,130 shares outstanding.
What happened to Blau Farmaceutica SA’s price movement after its last earnings report?
Blau Farmaceutica SA reported an EPS of $0.166 in its last earnings report, missing expectations of $0.234. Following the earnings report the stock price went down -1.791%.
Which hedge fund is a major shareholder of Blau Farmaceutica SA?
Currently, no hedge funds are holding shares in BR:BLAU3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blau Farmaceutica SA
Blau Farmacêutica S.A. operates as a pharmaceutical enterprise, supplying private label medications across Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. Its extensive product portfolio encompasses a broad spectrum of therapeutic areas, including immunology, hematology, oncology, nephrology, specialized treatments, and antibiotics. The company's offerings also extend to biological drugs, oral and injectable therapies for cancer, specialized treatments for infectious diseases, and a range of prescription and over-the-counter products like dermo-medicines and contraceptives, catering to both retail and non-retail markets. Additionally, Blau provides pharmaceuticals derived from blood, biological and biotechnological agents, and antiretroviral drugs. Its client base includes hospitals, private medical clinics, chemotherapy and hemodialysis centers, and public health institutions. Established in 1987, the firm's corporate headquarters are situated in Cotia, Brazil.
Hypera S.A.
―
Ourofino S.A.
―
Profarma Distribuidora de Produtos Farmaceuticos SA
―
Empreendimentos Pague Menos SA
―
Dimed S.A. Distribuidora de Medicamentos
―